{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:24:01Z","timestamp":1767666241127},"reference-count":51,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1857,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1111\/j.1399-3062.2010.00506.x","type":"journal-article","created":{"date-parts":[[2010,4,19]],"date-time":"2010-04-19T16:19:30Z","timestamp":1271693970000},"page":"358-362","source":"Crossref","is-referenced-by-count":13,"title":["Should intravesical Bacillus Calmette-Gu\u00e9rin be employed in transplant recipients with bladder carcinoma?"],"prefix":"10.1111","volume":"12","author":[{"given":"H.-Y.","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,20]]},"reference":[{"issue":"(4","key":"10.1111\/j.1399-3062.2010.00506.x-BIB1|cit1","first-page":"894","article-title":"Kidney and pancreas transplantation in the United States, 1998-2007","volume":"9","author":"McCullough","year":"2009","journal-title":"access for patients with diabetes and end-stage renal disease"},{"issue":"(2","key":"10.1111\/j.1399-3062.2010.00506.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA"},{"issue":"(9","key":"10.1111\/j.1399-3062.2010.00506.x-BIB3|cit3","first-page":"59","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients","volume":"370","author":"Grulich","year":"2007","journal-title":"a meta-analysis"},{"issue":"(9","key":"10.1111\/j.1399-3062.2010.00506.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/TP.0b013e3181a238f6","article-title":"De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population","volume":"87","author":"Miao","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-3062.2010.00506.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.juro.2009.06.043","article-title":"Patients with renal transplant or end-stage renal disease present with more advanced bladder cancer","volume":"182","author":"Ehdaie","year":"2009","journal-title":"J Urol"},{"issue":"(8","key":"10.1111\/j.1399-3062.2010.00506.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1600-6143.2009.02728.x","article-title":"Cancer mortality in kidney transplantation","volume":"9","author":"Kiberd","year":"2009","journal-title":"Am J Transplant"},{"issue":"(4","key":"10.1111\/j.1399-3062.2010.00506.x-BIB7|cit7","first-page":"S65","article-title":"Long-term patient survival","volume":"47","author":"Adams","year":"2006","journal-title":"strategies to improve overall health"},{"issue":"(1","key":"10.1111\/j.1399-3062.2010.00506.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/00007890-200206270-00013","article-title":"The changing causes of graft loss and death after kidney transplantation","volume":"73","author":"Howard","year":"2002","journal-title":"Transplantation"},{"issue":"(6","key":"10.1111\/j.1399-3062.2010.00506.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1600-6143.2004.00450.x","article-title":"Cancer after kidney transplantation in the United States","volume":"4","author":"Kasiske","year":"2004","journal-title":"Am J Transplant"},{"issue":"(4","key":"10.1111\/j.1399-3062.2010.00506.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1600-6143.2007.01736.x","article-title":"Cancer incidence among Canadian kidney transplant recipients","volume":"7","author":"Villeneuve","year":"2007","journal-title":"Am J Transplant"},{"issue":"(1","key":"10.1111\/j.1399-3062.2010.00506.x-BIB11|cit11","first-page":"30","article-title":"Bladder carcinoma among live-donor renal transplant recipients","volume":"101","author":"Kamal","year":"2008","journal-title":"a single-centre experience and a review of the literature"},{"issue":"(3","key":"10.1111\/j.1399-3062.2010.00506.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/01.ju.0000110612.42382.0a","article-title":"Treatment and outcome of invasive bladder cancer in patients after renal transplantation","volume":"171","author":"Master","year":"2004","journal-title":"J Urol"},{"key":"10.1111\/j.1399-3062.2010.00506.x-BIB13|cit13","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003231","article-title":"Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer","volume":"3","author":"Shelley","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"(2","key":"10.1111\/j.1399-3062.2010.00506.x-BIB14|cit14","first-page":"405","article-title":"Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder","volume":"173","author":"De Reijke","year":"2005","journal-title":"results of a European Organization for the Research and Treatment of Cancer - Genito-Urinary Group Phase III Trial (30906)"},{"issue":"(4","key":"10.1111\/j.1399-3062.2010.00506.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.urolonc.2007.11.031","article-title":"Role of neutrophils in BCG immunotherapy for bladder cancer","volume":"26","author":"Simons","year":"2008","journal-title":"Urol Oncol"},{"issue":"(2","key":"10.1111\/j.1399-3062.2010.00506.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med"},{"issue":"(6","key":"10.1111\/j.1399-3062.2010.00506.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0022-5347(17)38622-6","article-title":"Internalization of bacille Calmette-Guerin by bladder tumor cells","volume":"145","author":"Becich","year":"1991","journal-title":"J Urol"},{"issue":"(3","key":"10.1111\/j.1399-3062.2010.00506.x-BIB18|cit18","first-page":"611","article-title":"Novel insights into the mechanism of action of intravesical immunomodulators","volume":"19","author":"Mitropoulos","year":"2005","journal-title":"In Vivo"},{"issue":"(6","key":"10.1111\/j.1399-3062.2010.00506.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF01534428","article-title":"Induction of TH1- and TH2-associated cytokine mRNA in mouse bladder following intravesical growth of the murine bladder tumor MB49 and BCG immunotherapy","volume":"39","author":"McAveney","year":"1994","journal-title":"Cancer Immunol Immunother"},{"issue":"(1","key":"10.1111\/j.1399-3062.2010.00506.x-BIB20|cit20","first-page":"26","article-title":"Induction of tumour necrosis factor-alpha (TNF-alpha) mRNA in bladders and spleens of mice after intravesical administration of bacillus Calmette-Gu\u00e9rin","volume":"100","author":"Shin","year":"1995","journal-title":"Clin Exp Immunol"},{"issue":"(1","key":"10.1111\/j.1399-3062.2010.00506.x-BIB21|cit21","first-page":"17","article-title":"Role of Th1 and Th2 cytokines in BCG-induced IFN-gamma production","volume":"21","author":"Luo","year":"2003","journal-title":"cytokine promotion and simulation of BCG effect"},{"issue":"(1","key":"10.1111\/j.1399-3062.2010.00506.x-BIB22|cit22","first-page":"61","article-title":"Interleukin-12 regulates the production of Bacille Calmette-Guerin-induced interferon-gamma from human cells in a CD40-dependent manner","volume":"50","author":"Mendez-Samperio","year":"1999","journal-title":"Scand J Immunol"},{"issue":"(5","key":"10.1111\/j.1399-3062.2010.00506.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0022-5347(05)66410-5","article-title":"The fate of bacillus Calmette-Guerin after intravesical instillation","volume":"165","author":"Durek","year":"2001","journal-title":"J Urol"},{"issue":"(6","key":"10.1111\/j.1399-3062.2010.00506.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF01741603","article-title":"Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guerin","volume":"33","author":"De Boer","year":"1991","journal-title":"Cancer Immunol Immunother"},{"issue":"(1","key":"10.1111\/j.1399-3062.2010.00506.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1158\/0008-5472.CAN-06-1416","article-title":"Neutrophil granulocytes are required for effective Bacillus Calmette-Guerin immunotherapy of bladder cancer and orchestrate local immune responses","volume":"66","author":"Suttmann","year":"2006","journal-title":"Cancer Res"},{"issue":"(5","key":"10.1111\/j.1399-3062.2010.00506.x-BIB26|cit26","first-page":"1557","article-title":"CD4 T\u2003 cells","volume":"112","author":"Zhu","year":"2008","journal-title":"fates, functions, and faults"},{"issue":"(8","key":"10.1111\/j.1399-3062.2010.00506.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00262-003-0384-9","article-title":"Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Guerin immunotherapy for carcinoma in situ of the bladder","volume":"52","author":"Watanabe","year":"2003","journal-title":"Cancer Immunol Immunother"},{"issue":"(6","key":"10.1111\/j.1399-3062.2010.00506.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1200\/JCO.1996.14.6.1778","article-title":"Prediction of response to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression","volume":"14","author":"Kaempfer","year":"1996","journal-title":"J Clin Oncol"},{"issue":"(1","key":"10.1111\/j.1399-3062.2010.00506.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-5347(17)43909-7","article-title":"Requirement of a thymus dependent immune response for BCG-mediated antitumor activity","volume":"137","author":"Ratliff","year":"1987","journal-title":"J Urol"},{"issue":"(3","key":"10.1111\/j.1399-3062.2010.00506.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0022-5347(17)35678-1","article-title":"T-cell subsets required for intravesical BCG immunotherapy for bladder cancer","volume":"150","author":"Ratliff","year":"1993","journal-title":"J Urol"},{"issue":"(4","key":"10.1111\/j.1399-3062.2010.00506.x-BIB31|cit31","first-page":"532","article-title":"Conversion from cyclosporine A to tacrolimus in pediatric kidney transplant recipients with chronic rejection","volume":"77","author":"Ferraris","year":"2004","journal-title":"changes in the immune responses"},{"issue":"(8","key":"10.1111\/j.1399-3062.2010.00506.x-BIB32|cit32","first-page":"1084","article-title":"Immunosuppressive drugs in islet xenotransplantation","volume":"74","author":"Krook","year":"2002","journal-title":"a tool for gaining further insights in the mechanisms of the rejection process"},{"issue":"(1","key":"10.1111\/j.1399-3062.2010.00506.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ndt\/13.1.160","article-title":"Suppression of the humoral immune response by mycophenolate mofetil","volume":"13","author":"Smith","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"(9","key":"10.1111\/j.1399-3062.2010.00506.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"issue":"(5","key":"10.1111\/j.1399-3062.2010.00506.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1365-3083.1999.00538.x","article-title":"Methyl-prednisolone up-regulates monocyte interleukin-10 production in stimulated whole blood","volume":"49","author":"Hodge","year":"1999","journal-title":"Scand J Immunol"},{"issue":"(S","key":"10.1111\/j.1399-3062.2010.00506.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1086\/314064","article-title":"Efficacy and safety of bacille Calmette-Guerin immunotherapy in superficial bladder cancer","volume":"31","author":"Lamm","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"(3","key":"10.1111\/j.1399-3062.2010.00506.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-5347(17)37316-0","article-title":"Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer","volume":"147","author":"Lamm","year":"1992","journal-title":"J Urol"},{"issue":"(2","key":"10.1111\/j.1399-3062.2010.00506.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/344908","article-title":"Spectrum of bacille Calmette-Gu\u00e9rin (BCG) infection after intravesical BCG immunotherapy","volume":"36","author":"Gonzalez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1399-3062.2010.00506.x-BIB39|cit39","volume-title":"UpToDate","author":"O'Donnell","year":"2009"},{"issue":"(6","key":"10.1111\/j.1399-3062.2010.00506.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0755-4982(06)74732-7","article-title":"[Acute respiratory failure and septic shock induced by Mycobacterium bovis. A rare side effect of intravesical BCG therapy] (brackets=article in foreign language)","volume":"35","author":"Rival","year":"2006","journal-title":"Presse Med"},{"issue":"(1","key":"10.1111\/j.1399-3062.2010.00506.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/SMJ.0b013e31815d4047","article-title":"Four cases of disseminated Mycobacterium bovis infection following intravesical BCG instillation for treatment of bladder carcinoma","volume":"101","author":"Nadasy","year":"2008","journal-title":"South Med J"},{"issue":"(1","key":"10.1111\/j.1399-3062.2010.00506.x-BIB42|cit42","first-page":"188","article-title":"Psoas abscess following intravesical bacillus Calmette-Guerin for bladder cancer","volume":"150","author":"Hakim","year":"1993","journal-title":"a case report"},{"issue":"(1","key":"10.1111\/j.1399-3062.2010.00506.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/00007611-199512000-00005","article-title":"Vascular and other serious infections with Mycobacterium bovis after bacillus of Calmette-Guerin therapy for bladder cancer","volume":"88","author":"Hellinger","year":"1995","journal-title":"South Med J"},{"issue":"(2","key":"10.1111\/j.1399-3062.2010.00506.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/520238","article-title":"Disseminated infection after bacille Calmette-Guerin instillation for treatment of bladder carcinoma","volume":"29","author":"Viallard","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"(5","key":"10.1111\/j.1399-3062.2010.00506.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0002-9394(99)00206-8","article-title":"Endophthalmitis from Mycobacterium bovis-bacille Calmette-Guerin after intravesicular bacille Calmette-Guerin injections for bladder carcinoma","volume":"128","author":"Han","year":"1999","journal-title":"Am J Ophthalmol"},{"issue":"(2","key":"10.1111\/j.1399-3062.2010.00506.x-BIB46|cit46","first-page":"476","article-title":"Intravesical instillation of epirubicin, bacillus Calmette-Guerin and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder","volume":"166","author":"Van Der Meijden","year":"2001","journal-title":"a European Organization for Research and Treatment of Cancer genito-urinary group randomized phase III trial"},{"issue":"(4","key":"10.1111\/j.1399-3062.2010.00506.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1464-410X.1990.tb14971.x","article-title":"Granulomatous hepatitis following intravesical BCG therapy","volume":"66","author":"Thompson","year":"1990","journal-title":"Br J Urol"},{"issue":"(1","key":"10.1111\/j.1399-3062.2010.00506.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.purol.2008.08.002","article-title":"[Carcinoma in situ in bladder and urethra among renal transplanted patient: failure of BCG therapy] foreign-language article","volume":"18","author":"Tillou","year":"2008","journal-title":"Prog Urol"},{"issue":"(1","key":"10.1111\/j.1399-3062.2010.00506.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1097\/01.TP.0000090748.32764.0F","article-title":"Intravesical bacillus Calmette-Guerin for the treatment of superficial bladder cancer in renal transplant patients","volume":"76","author":"Palou","year":"2003","journal-title":"Transplantation"},{"issue":"(6","key":"10.1111\/j.1399-3062.2010.00506.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1034\/j.1399-0012.2002.01152.x","article-title":"The outcome of post-transplant transitional cell carcinoma in 10 renal transplant recipients","volume":"16","author":"Wang","year":"2002","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1399-3062.2010.00506.x-BIB51|cit51","article-title":"Intravesical Bacillus Calmette-Guerin in Ta and T1 bladder cancer","volume":"4","author":"Shelley","year":"2000","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2010.00506.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1399-3062.2010.00506.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T01:47:21Z","timestamp":1625622441000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2010.00506.x"}},"subtitle":["BCG in transplant recipients"],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2010.00506.x","relation":{},"ISSN":["1398-2273"],"issn-type":[{"value":"1398-2273","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}